Guselkumab Shows Similar Domain-Specific Efficacy in Females and Males with Active Psoriatic Arthritis: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies

被引：0

作者：

Eder, Lihi ^{[1
,2
]}

Selmi, Carlo ^{[3
]}

Mease, Philip ^{[4
,5
]}

Ogdie, Alexis ^{[6
]}

Nantel, Francois ^{[7
]}

Lavie, Frederic ^{[8
]}

Sharaf, Mohamed ^{[9
]}

Adelakun, Oyediran ^{[10
]}

Rampakakis, Emmanouil ^{[11
]}

Vegas, Laura Pina ^{[12
]}

Coates, Laura ^{[13
]}

机构：

[1] Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada

[2] Dept Med, Toronto, ON, Canada

[3] IRCCS Ist Clin Humanitas, Rozzano, Italy

[4] Providence St Joseph, Swedish Med Ctr, Seattle, WA USA

[5] Univ Washington, Sch Med, Seattle, WA USA

[6] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA USA

[7] Nantel MedSci Consult, Montreal, PQ, Canada

[8] Janssen Cilag Global Med Affairs, Immunol Global Med Affairs, Issy Les Moulineaux, France

[9] Middle East FZ LLC, Johnson & Johnson, Dubai, U Arab Emirates

[10] Janssen Res Dev LLC, Titusville, NJ USA

[11] McGill Univ, Dept Pediat Sci Affairs, JSS Med Res Inc, Montreal, PQ, Canada

[12] Leiden Univ, Med Ctr, Leiden, Netherlands

[13] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2342

引用

页码：4720 / 4722

页数：3

共 50 条

[1] Guselkumab Efficacy in Active Psoriatic Arthritis Patients with or Without Hyperuricemia: Post-hoc Analysis of Two Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
Felten, Renaud
Widawski, Laura
Spielman, Lionel
Gottenberg, Jacques-Eric
Duret, Pierre-Marie
Rampakakis, Emmanouil
Sharaf, Mohamed
Constantin, Caren
Campana, Vincenza
Messer, Laurent
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4429 - 4432
[2] Efficacy of guselkumab in bionaive psoriatic arthritis patients with severe disease activity: post hoc analysis of Phase 3, randomized, double-blind, placebo-controlled study
Ritchlin, Christopher T.
Lubrano, Ennio
Chimenti, Maria Sole
Leibowitz, Evan
Sharaf, Mohamed
Rampakakis, Emmanouil
Chakravarty, Soumya
Nantel, Francois
Lavie, Frederic
Deodhar, Atul
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
[3] Efficacy of Guselkumab in Bionaive Psoriatic Arthritis Patients with Severe Disease Activity: Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Ritchlin, Christopher
Lubrano, Ennio
Chimenti, Maria Sole
Leibowitz, Evan
Sharaf, Mohamed
Adelakun, Oyediran
Rampakakis, Emmanouil
Nantel, Francois
Lavie, Frederic
Deodhar, Atul
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2999 - 3001
[4] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Deodhar, Atul
Gottlieb, Alice B.
Boehncke, Wolf-Henning
Dong, Bin
Wang, Yuhua
Zhuang, Yanli
Barchuk, William
Xu, Xie L.
Hsia, Elizabeth C.
LANCET, 2018, 391 (10136) : 2213 - 2224
[5] Sex-Related Differences in Baseline Patient and Disease Characteristics: Post Hoc Analyses of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies in Patients with Active Psoriatic Arthritis
Coates, Laura
Selmi, Carlo
Mease, Philip
Ogdie, Alexis
Nantel, Francois
Lavie, Frederic
Sharaf, Mohamed
Adelakun, Oyediran
Rampakakis, Emmanouil
Vegas, Laura Pina
Eder, Lihi
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1198 - 1200
[6] Efficacy of ixekizumab in patients with psoriatic arthritis: Results of a phase 3 randomized, double-blind, active- and placebo-controlled study
Mease, Philip
van der Heijde, Desiree
Ritchlin, Christopher
Cuchacovich, Rachel
Shuler, Catherine
Lin, Chen-Yen
Vangerow, Harald
Samanta, Suvajit
Lee, Chin
Gladman, Dafna
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
[7] Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study
Coates, Laura C.
Gossec, Laure
Zimmermann, Miriam
Shawi, May
Rampakakis, Emmanouil
Shiff, Natalie J.
Kollmeier, Alexa P.
Xu, Xie L.
Nash, Peter
Mease, Philip J.
Helliwell, Philip S.
RMD OPEN, 2024, 10 (01):
[8] Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study
Coates, Laura C.
Rahman, Proton
Mease, Philip J.
Shawi, May
Rampakakis, Emmanouil
Kollmeier, Alexa P.
Xu, Xie L.
Chakravarty, Soumya D.
McInnes, Iain B.
Tam, Lai-Shan
BMC RHEUMATOLOGY, 2024, 8 (01)
[9] Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study
Laura C. Coates
Proton Rahman
Philip J. Mease
May Shawi
Emmanouil Rampakakis
Alexa P. Kollmeier
Xie L. Xu
Soumya D. Chakravarty
Iain B. McInnes
Lai-Shan Tam
BMC Rheumatology, 8
[10] Impact of Psoriatic Arthritis Manifestations on Perception of Pain Improvement: Pooled Analysis of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Studies with Guselkumab
Nash, Peter
McInnes, Iain
Ritchlin, Christopher T.
Tam, Lai-Shan
Soriano, Enrique
Starr, Michael
Rampakakis, Emmanouil
Lavie, Frederic
Shawi, May
Baraliakos, Xenofon
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2785 - 2787

← 1 2 3 4 5 →